NeutriSci International Inc
XTSX:NU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
NeutriSci International Inc
Common Shares Outstanding
NeutriSci International Inc
Common Shares Outstanding Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
NeutriSci International Inc
XTSX:NU
|
Common Shares Outstanding
CA$178.4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Flora Growth Corp
NASDAQ:FLGC
|
Common Shares Outstanding
$474.7k
|
CAGR 3-Years
78%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
Genix Pharmaceuticals Corp
XTSX:GENX
|
Common Shares Outstanding
CA$61.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
|
|
Vitality Products Inc
XTSX:VPI
|
Common Shares Outstanding
CA$41.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
Jamieson Wellness Inc
TSX:JWEL
|
Common Shares Outstanding
CA$41.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
L
|
Leef Brands Inc
CNSX:LEEF
|
Common Shares Outstanding
$185.8m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
NeutriSci International Inc
Glance View
NeutriSci International Inc. is like a modern-day alchemist in the wellness sector, transforming scientific research into innovative consumer products. Nestled in the bustling world of nutraceuticals, the company has carved out a unique niche by leveraging partnerships and technology to create scientifically backed, consumer-focused nutraceutical products. Its flagship offerings revolve around energy and wellness, utilizing patented technology to deliver precise and effective doses of active ingredients, particularly through dissolvable tablets. By using cutting-edge science to craft novel delivery mechanisms, NeutriSci makes its mark in a market that is ever-thirsty for the next advancement in health supplementation. The business model thrives on collaborations with industry giants and strategic ventures, enabling NeutriSci to scale its distribution and enhance its product portfolio. These partnerships not only increase market reach but also bring a level of credibility and robustness to the brand. Revenue generation is predominantly anchored in product sales, driven by consumer awareness and a growing demand for easy-to-use, efficient health supplements. By focusing on expanding its technological capabilities and maintaining a pulse on consumer trends, NeutriSci positions itself as a forward-thinking leader in the nutraceutical sector, aiming to meet the burgeoning demand for health-enhancing, convenient solutions.
See Also
What is NeutriSci International Inc's Common Shares Outstanding?
Common Shares Outstanding
178.4m
CAD
Based on the financial report for Sep 30, 2023, NeutriSci International Inc's Common Shares Outstanding amounts to 178.4m CAD.
What is NeutriSci International Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
12%
Over the last year, the Common Shares Outstanding growth was 7%. The average annual Common Shares Outstanding growth rates for NeutriSci International Inc have been 6% over the past three years , 12% over the past five years .